The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma
Clinical trial NCT03022123 · UNKNOWN
Trial details
- NCT number
- NCT03022123
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-11-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.